University Hospitals Plymouth NHS Trust

Organisation

Grants and prizes

National Institute for Health and Care Research
Efficacy and Mechanism Evaluation, A randomised placebo-controlled superiority trial of GLP-1 receptor agonist for the treatment of alcohol use disorder in people with chronic liver disease and obesity: Controlling Unhealthy Relationships with Both alcohol and obesity (CURB trial), NIHR170284, £2.8m, 2026–2030, 1 Sept 2026
National Institute for Health and Care Research
Research for Patient Benefit, ?-hydroxy ß-methylbutyrate (HMB) supplementation to optimise outcomes in advanced liver cirrhosis (BOOST): a multicentre double blind placebo-controlled randomised trial, NIHR206170, £508.4k, 2024–2027, 3 Jun 2024
National Institute for Health and Care Research
Programme Grants for Applied Research, How are treatment outcomes for people with severe obesity ImPROved by GROUP-based behavioural intervention?, NIHR201038, £2.5m, 2021–2026, 1 May 2021
National Institute for Health and Care Research
Research for Patient Benefit, Statin Treatment Options during vaccination against inFLUenza (STOPFlu) : an observational study of the interaction between statins and influenza vaccination, NIHR202012, £181.2k, 2021–2022, 4 Jan 2021
National Institute for Health and Care Research
Health Technology Assessment, A multi-centred Trial of physical Activity assisted Reduction of Smoking (TARS), 15/111/01, £1.9m, 2017–2020, 1 May 2017